during a follow-up period of 3 weeks to 4 months , no significant ocular changes were noted following a single injection of bcnu into the vitreous ( 0.002 -- 0.50 mg ) or anterior chamber ( 0.001 -- 0.250 mg ) , or 10 daily subtenon-retrobulbar injections ( 0.5 -- 1.0 mg each ) .
C0015392
ocular
C0003151
anterior chamber